Title : Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib.

Pub. Date : 2009 Jan 22

PMID : 18922853






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib. Bortezomib CD34 molecule Homo sapiens
2 Bortezomib up-regulated TRAIL receptor expression on quiescent CD34(+) CML cells, and further enhanced their susceptibility to cytotoxicity by in vitro expanded donor NK cells. Bortezomib CD34 molecule Homo sapiens